ArticleBiomolecules & therapeutics2019

An Anti-Cancer Drug Candidate CYC116 Suppresses Type I Hypersensitive Immune Responses through the Inhibition of Fyn Kinase in Mast Cells.

Young Hwan Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.